AZULFIDINE EN-TABS Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Azulfidine En-tabs, and what generic alternatives are available?
Azulfidine En-tabs is a drug marketed by Pfizer and is included in one NDA.
The generic ingredient in AZULFIDINE EN-TABS is sulfasalazine. There are ten drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the sulfasalazine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Azulfidine En-tabs
A generic version of AZULFIDINE EN-TABS was approved as sulfasalazine by WATSON LABS on December 31st, 1969.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for AZULFIDINE EN-TABS?
- What are the global sales for AZULFIDINE EN-TABS?
- What is Average Wholesale Price for AZULFIDINE EN-TABS?
Summary for AZULFIDINE EN-TABS
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 141 |
| Clinical Trials: | 4 |
| Patent Applications: | 325 |
| DailyMed Link: | AZULFIDINE EN-TABS at DailyMed |
Recent Clinical Trials for AZULFIDINE EN-TABS
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Erlangen-Nürnberg Medical School | Phase 3 |
| Brigham and Women's Hospital | Phase 4 |
| Columbia University | Phase 4 |
Pharmacology for AZULFIDINE EN-TABS
| Drug Class | Aminosalicylate |
US Patents and Regulatory Information for AZULFIDINE EN-TABS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | AZULFIDINE EN-TABS | sulfasalazine | TABLET, DELAYED RELEASE;ORAL | 007073-002 | Apr 6, 1983 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
